Using Scrambler Therapy to treat pain after a stroke
Official title: Scrambler Therapy for Post-Stroke Pain
Run by Johns Hopkins University · NCT05563038 · Data updated 2026-11-12
This study is testing if Scrambler Therapy can help people who have pain after a stroke feel better compared to regular pain medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | May 15, 2023 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | January 26, 2026 |
| Trial ID | NCT05563038 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 who have experienced an ischemic or hemorrhagic stroke and have pain in areas affected by their stroke.
✕Probably not a fit
Patients with transient ischemic attacks, no evidence of stroke on MRI, or those with certain medical devices or conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of Scrambler Therapy compared to traditional pharmacologic treatments for patients experiencing post-stroke pain. Participants will be enrolled if they are at least one month post-stroke and have pain related to their stroke location. They will choose their preferred treatment method and will be monitored for pain relief over the course of a year using standardized pain scores. The study will compare the maximum pain relief and duration of relief achieved between the two treatment groups.
Why it matters
Potential benefit: If successful, this study could provide an alternative pain management option for patients suffering from post-stroke pain.
How similar studies have gone: While Scrambler Therapy is a novel approach, similar studies have shown promising results in pain management, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women over the age of 18 with ischemic or hemorrhagic stroke seen on imaging and a positive finding for pain in the area(s) affected by their stroke location will be included. * The patients must be at least one month post-stroke but can otherwise enroll at any point. Exclusion Criteria: * Patients with TIA * Patients with no evidence of stroke on MRI * Patients with implantable devices such as pacemakers, defibrillators, spinal cord stimulators * Patients with history of myocardial infarction in the past 6 months * Patients with uncontrolled epilepsy * Patients with symptomatic brain metastases
Where it's running
-
Johns Hopkins Bayview Hospital
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Dawn Merbach, MNP — Johns Hopkins University
- Study coordinator: Dawn Merbach, MNP
- Email: dmerbac1@jhmi.edu
- Phone: 4105508065
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
At-home ear neurostimulation for chronic post-stroke upper limb pain
This study will try daily at-home ear nerve stimulation for people with chronic upper-arm pain after a stroke to see if it lowers their pain.
-
New technology for deep brain stimulation to treat chronic pain
This study is testing a new type of brain stimulation to see if it can help people with chronic pain that doesn't respond to regular treatments.
-
Psilocybin-assisted therapy to help adults with amblyopia see more clearly
This study tests whether a single or small doses of psilocybin can boost the effectiveness of amblyopia treatment in adults.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
Social Connection Collective for older adults in subsidized housing
A resident-led program in subsidized housing in Baltimore will try to build friendships and peer support among residents aged 62 and older to see if it’s feasible and if it reduces loneliness.
-
Oral Food Challenge After Starting Omalizumab in Food Allergy
This trial tests whether omalizumab begins to help with food allergy within 2 to 4 weeks after starting treatment in people with a confirmed food allergy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.